Читать книгу "0,05. Доказательная медицина от магии до поисков бессмертия - Петр Талантов"

Rousakis A., Vlassis A., Vlanti A., Patera S., Thireos G., Syntichaki P. The general control nonderepressible-2 kinase mediates stress response and longevity induced by target of rapamycin inactivation in Caenorhabditis elegans // Aging Cell. 2013. Vol. 12. № 5. P. 742–751.

Baur J. A., Pearson K. J., Price N. L., Jamieson H. A., Lerin C., Kalra A. et al. Resveratrol improves health and survival of mice on a high-calorie diet // Nature. 2006. November 16. Vol. 444. № 7117. P. 337–342.

Pearson K. J., Baur J. A., Lewis K. N., Peshkin L., Price N. L., Labinskyy N. et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span // Cell metabolism. 2008. August. Vol. 8. № 2. P. 157–168.

Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the ‘French paradox’? // European Journal of Endocrinology. 1998. June. Vol. 138. № 6. P. 619–620.

Goldberg D. M., Yan J., Soleas G. J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects // Clinical biochemistry. 2003. February. Vol. 36. № 1. P. 79–87.

Law M., Wald N. Why heart disease mortality is low in France: the time lag explanation // BMJ. 1999. May 29. Vol. 318. № 7196. P. 1471–1480.

Vang O. What is new for resveratrol? Is a new set of recommendations necessary? // Annals of the New York Academy of Sciences. 2013. July. Vol. 1290. № 1. P. 1–11.

Vaziri H., Dragowska W., Allsopp R. C., Thomas T. E., Harley C. B., Lansdorp P. M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age // PNAS. 1994. October 11. Vol. 91. № 21. P. 9857–9860.

Jodczyk S., Fergusson D. M., Horwood L. J., Pearson J. F., Kennedy M. A. No association between mean telomere length and life stress observed in a 30 year birth cohort // PLoS One. 2014. Vol. 9. № 5, e97102.

Chae D. H., Nuru-Jeter A. M., Adler N. E., Brody G. H., Lin J., Blackburn E. H., Epel E. S. Discrimination, racial bias, and telomere length in African-American men // American journal of preventive medicine. 2014. February. Vol. 46. № 2. P. 103–111.

Jaskelioff M., Muller F. L., Paik J.-H., Thomas E., Jiang S., Adams A. et al. Telomerase reactivation reverses tissue degeneration in aged telomerase deficient mice // Nature. 2011. January 6. Vol. 469. № 7328. P. 102–106.

Sprouse A. A., Steding C. E., Herbert B.-S. Pharmaceutical regulation of telomerase and its clinical potential // Journal of cellular and molecular medicine. 2012. January. Vol. 16. № 1. P. 1–7.

Sanders J. L., Newman A. B. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? // Epidemiologic Reviews. 2013. January 1. Vol. 35. № 1. P. 112–131.